Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001465652-18-000004

Options or other derivatives

  • Chief Science/Medical Officer acquired 75,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
STRAYER DAVID R Chief Science/Medical Officer 2018-04-12 Grant or award · Options to buy Common Stock +75,000 75,000 D
Loading xslF345X03/primary_doc.xml…